News & Perspective

Oct 01, 2019

Oct 01, 2019

News Scan for Oct 01, 2019

More DRC Ebola
Universal flu vaccine network launch
Passive immunity for flu
Zoonotic flu vaccine strain
Basil-linked Cyclospora
US bio-, agro-defense center head

Aug 12, 2019

Aug 12, 2019
Alima cube

Ebola outbreak treatment trial narrowed to two promising drugs

Officials hope the promising treatment findings encourage more patients to seek lifesaving treatment.

Apr 03, 2019

Apr 03, 2019

News Scan for Apr 03, 2019

Ebola Bombali in Kenyan bats
Universal flu vaccine trial
E coli O103 in 4 states
Lassa fever in Nigeria
Waterborne hospital infections

Feb 12, 2019

Feb 12, 2019

News Scan for Feb 12, 2019

More Saudi MERS cases
Yellow fever in Brazil
Lassa fever in Guinea and Nigeria
Zika in Mexico
Gain-of-function H5N1 studies to resume

Oct 30, 2018

Oct 30, 2018
ebola vaccine

Ebola total hits 276 as lasting effect noted for 3 vaccines

Immune response lasted 2.5 years for the vaccines, the longest yet in ongoing studies of Ebola immunization.

Aug 16, 2018

Aug 16, 2018
vaccine research

CEPI announces new collaboration and funding for Lassa vaccine

The announcement comes as Nigeria is experiencing its largest outbreak, with 481 confirmed cases reported as of last week, 133 of them fatal.

Jan 10, 2018

Jan 10, 2018

News Scan for Jan 10, 2018

Ebola antibody findings
USDA egg product rule
1918 pandemic flu severity

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Feb 28, 2017

Feb 28, 2017

News Scan for Feb 28, 2017

Zika study rejected
Asymptomatic Ebola
MERS cases
CEPI names CEO
Biosecurity lab in China

Mar 31, 2015

Mar 31, 2015
Lab worker with test tubes

BioCryst gets HHS contract for Ebola drug development

Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»